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REPORT OF THE PRESIDENT 




Because it is my first annual report as president, this writing is a 
panoramic personal reflection of my views of The Rockefeller Uni­
versity. This first year has remarkably confirmed my optimistic 
expectations about the University. My greatest surprise was to have 
experienced so few surprises about the kind of place it is and the kind 
of people who work here. 
Three years ago, The Rockefeller University- founded in 190 I 
as The Rockefeller Institute for Medical Research-observed its 75th 
anniversary. A theme of the celebration was the continuity of the 
tradition and achievement which marked the transition from Institute 
to University. As I noted in my inaugural remarks last October, the 
record of that anniversary reflects the success of the transition and 
also dramatizes the opportunities that drew me here: to conserve and 
enhance the most vital tradition of biomedical research to be found 
anywhere today. 
In keeping with the vitality of this tradition, many of the things I 
write will not now, nor in the future, appear as radical innovations. 
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It is my hope that, if events allow, they may bear repeating several 
years from now. I welcome the opportunity to define, in the light of 
contemporary circumstances, the spirit in which I approach my new 
responsibilities. 
The substantial scope, simple structure,'and coherent goals of this 
University offer a unique challenge to scientific leadership. Certainly 
today we have a broader conception than existed in 1901 of the 
scientific foundation needed for an understanding of human biology. 
Thanks, in large part, to the inspiration of the late Detlev W. Bronk, 
the University has incorporated the behavioral sciences and broad­
ened the base of the physical sciences on this campus. It was President 
Bronk who brought Carl Pfaffmann here to develop the University's 
strong program of behavioral studies. Dr. Pfaffman, who retired this 
year as vice president, continues to head one of our physiological 
psychology laboratories. The distinction of our physics and mathe­
matics faculties and their positions at the international forefront in 
their disciplines have added a stimulating new dimension to the 
intellectual life of this scientific community. But the scientific pro­
grams of the University, for all the diversity of fundamental and 
clinical research carried out in its 60 independent laboratories, remain 
firmly based on the biomedical sciences and sharply tuned to the 
protection and improvement of the health of the human species. 
In leading institutions that have multiple concerns and aims, as is 
typical of many larger universities, presidents are preoccupied with 
negotiating compromises between disparate sets of values. This is a 
leadership challenge of a rather different kind and implies a strong 
political role. But here basic political questions are, in a sense, already 
settled: first by the University's coherence of goals, and second by its 
fundamental structure. 
Our University is unusual in not being divided into schools with 
competing interests and distinctive concerns such as law, medicine, or 
engineering. We have no division of undergraduate studies competing 
for attention and resources for other purposes. Nor do we have 
academic departments which carve out sovereign intellectual territo­
ries. Instead, we are organized simply into individual laboratories, 
each led by a senior investigator. The work of the laboratory is, of 
course, shared by a varying number of junior faculty, postdoctoral 
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fellows, graduate students, and technicians. 
The usual departmental structure aggregates specialists within 
fairly closely bounded areas, within which intensive conceptual effort 
is supported. This style of organizational structure may be indispens­
able for the management of teaching or service functions. Yet it tends 
to isolate academic colleagues from those in other disciplines and 
hinders novel and boundary lines of research. These are very real 
obstacles to certain kinds of innovation. 
Our University could have had departments of physiology or 
biochemistry or pharmacology or pathology. But the conscious re­
nunciation of this pattern of organization, from the initial founding, 
has fostered innovative interdisciplinary research. (The continuous 
momentum of the scientific and educational work of the University 
during the past year is described in the publication Scientific and 
Educational Programs.) Some of the brief sketches of current research 
accompanying this report illustrate the quality of such interaction, 
which can start with a conversation in the cafeteria, a short stroll from 
one building to another on our compact 15-acre campus, or in the 
mind of a clinical researcher sensitized by continued laboratory 
contact to think "chemically" about a medical problem. It is no 
accident that it is possible here for an organic chemist or a pharma­
cologist with a Ph.D. to be involved in clinical investigation of the 
highest quality. It is equally easy for a behavioral scientist to collab­
orate with a biochemist or a physiologist in uncovering the mecha­
nisms underlying behavioral data gathered in field studies. 
In addition, the University offers an opportunity for undistracted 
research, which is appealing to scientists who, at some institutions, 
might have to spend considerable time doing other things, useful and 
important but not directly related to their research. 
A Collegial Structure
A simile for this organization is that the president here functions like 
the head of a single academic department with a regular faculty of 
200 scientists. Now, whether 60 laboratories can report to one indi­
vidual, and sustain an acceptable degree of managerial effectiveness, 
raises questions that a beginning student of management will antici­
pate. Yet this simple structure has, over the decades, stimulated a 
continued on page 6 
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Male Chaffinch and sound spectrogram of complete song. 
Bird song, one of the most common and 
delightful natural sounds on earth, is a 
biologically important, complex form of 
reproductive behavior used by the avian 
male to attract and keep a mate and to 
defend the territory where he lives, mates, 
and nests. Peter Marler, head of the Uni­
versity's Field Research Center at Mill­
brook, N. Y., has found many parallels 
between bird song and human language. 
For one thing, probably all the Oscines -
songbirds, such as canaries, sparrows, 
robins, and finches - learn to sing the 
way humans learn to speak by listening to 
and imitating others of their species. Birds 
and human beings are the only creatures 
known to learn the sounds they use to 
exchange information. 
For almost a decade, Fernando Notte­
bohm, a colleague of Dr. Marler's, has col­
laborated with members of several Uni-
versity laboratories in interdisciplinary 
studies of songbird behavior, ranging 
across anatomy, neurophysiology, and 
biochemistry. Significant clues have 
emerged on how the brains of songbirds 
approach the task of vocal learning. 
Bird song is produced by the syrinx, a 
structure deep within the chest where the 
two bronchial tubes from the lungs join 
the trachea, or windpipe. In Oscines, the 
syrinx has two sound sources, the internal 
tympaniform membranes, which form part 
of the medial wall of each bronchus. Air 
rushes through the bronchi and past the 
tympanic membranes, which vibrate rap­
idly to produce sound. Pitch and loudness 
are modulated by the syringeal muscles, 
which set membrane tension and control 
airflow. Each half of the syrinx is inner­
vated by a branch of the hypoglossal 
nerve. 
When Dr. Nottebohm began his re­
search, virtually nothing was known about 
the neural pathways involved in song pro-
duction. Using behavioral studies and an­
atomical techniques, he and neuroanato­
mist Christiana Leonard traced central 
nervous pathways that control song in the 
canary. They described discrete vocal con­
trol areas in the brain where nerve path­
ways related to song production interface 
with centers for processing auditory infor­
mation. A totally unexpected, but highly 
significant, finding was that in songbirds, 
as in humans, the left hemisphere of the 
brain dominates vocal behavior. This was 
the first reported non-human example of 
hemispheric asymmetry, the concentra­
tion of a specific function on one side of 
the brain. 
Another important discovery, by Dr. 
Nottebohm and Arthur P. Arnold, was that 
brain vocal control areas in male songbirds 
are several times larger than in females. 
This so-called sexual dimorphism seems 
to be related to differences in behavior: 
male birds learn songs by imitation and 
sing profusely; females sing little, if at all. 
When reported in 1976, this was the first 
description of such a gross sexual differ­
ence in a vertebrate brain. 
There is a wide body of evidence that 
in both humans and animals sexual be­
havior is heavily influenced by steroid hor­
mones secreted by the gonads. They stim­
ulate such behavior by acting on nerve 
cells in the brain. For instance, testoster­
one, a male sex hormone, determines the 
amount of singing done by canaries and 
zebra finches. During the breeding season, 
normal males sing a lot. Castrated males 
sing very little, but this can be corrected 
by administering testosterone. Using ra-: 
dioactively tagged hormones, Dr. Arnold, 
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with the help of Dr. Donald Pfaff and as 
part of his thesis work in the Nottebohm 
laboratory, discovered that some vocal 
control stations in the songbird brain con­
centrate testosterone in their cells. In par­
ticular, the motoneurons which innervate 
the syringeal muscles also are hormone­
sensitive "target" cells. 
Several years ago, Dr. Nottebohm 
joined forces with Bruce McEwen 's group 
to see whether the anatomical and physi­
ological findings on bird song could be 
related more directly to biochemical ef­
fects on behavior. Dr. McEwen's labora­
tory group is seeking to learn how hor­
mones interact biochemically with nerve 
tissue to activate behavior. 
Doctors Nottebohm and Ivan Lieber­
burg established by test-tube experiments 
that syringeal muscle also has testoster­
one-sensitive cells. This suggests a direct 
hormonal influence on song-control mus­
cles. Experiments done with Doctors Vic­
toria N. Luine and Cheryl Harding indicate 
that testosterone is necessary for main­
taining the levels of an enzyme in the 
syringeal muscle that is important in neu­
romuscular transmission. Clearly, the ef­
fects of sex hormones on bird song occur 
at multiple levels, from the brain to the 
very muscles that modulate song. 
Dr. Nottebohm believes that the study 
of phenomena as disparate as hemispheric 
dominance, sexual dimorphism, and hor­
monal regulation of behavior is leading 
him to the more difficult and fascinating 
question of how learning affects brain 
pathways. He is confident that the avian 
brain, evolved to master song-learning, 
will also yield insights into this question. 
The Rockefeller University 6 
remarkable record of scientific achievement. Mainly bec�use, at the 
heart of it, is this truly collegial concept-to provide maximum 
incentive for the carefully selected and highly gifted individuals 
gathered here to relate to their fellow scientists across many different 
specialties of knowledge and styles of critical thinking. Whether there 
is any sense to having an institution of this kind at all depends on the 
extent to which "colleague-iality" is protected, fostered, and encour­
aged. This concept bears directly on our style of recruitment, on 
career advancement plans, on the identification of areas selected for 
emphasis in research, and on almost every other aspect of day-to-day 
life at the University. 
On a very personal level, I might describe myself as in a state of 
transitional reconstruction - after a leap from the laboratory bench 
to the board room - and wondering how to apply experience in 
scientific scholarship to organizational leadership. However, I have 
been confirmed in the belief that the inherent structure of The 
Rockefeller University lends itself to a president who has personally 
experienced the stresses, tedium, and thrills of the scientific pursuit. 
Exciting about this environment is the responsibility that it places on 
the president to fit into a collegial framework, to be sufficiently 
informed or educable to enter into critical judgments about the wide 
diversity of research in progress, to help bring people together from 
different parts of the network, and to participate in the critical 
dialogue that is the substance of scientific progress. Most of the people 
at the University work in areas that are familiar to me and that I care 
deeply about. This heightens my sense of the unparalleled opportunity 
offered here for intellectual adventure and human service. 
Scientific research is one of the most enthralling pursuits that can 
occupy the human mind, and those of us who can dedicate our 
lifework to it are privileged indeed. But the private excitement of 
discovery should not obscure the enormous public stakes of the 
enterprise. What we learn today about the structure of DNA and of 
cells and how these are knit together in a functioning organism will 
be indispensable tomorrow for what is indeed a war against pain, 
disease, and death. 
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Scie!ltific Direction 
Manifestly, I have not returned to Manhattan to chart major changes 
in institutional trajectory. Rather, I would aver that the University 
can best perform its social function by consolidating its scientific 
interests to hew more closely to the course implied in its original 
name. This orientation is consistent with the goals and priorities 
articulated by the preceding administration with our faculty and the 
University Board of Trustees. Nonetheless, constant reexamination of 
goals, priorities, and performance is an obligation of any institution 
in the present climate of skepticism and inquiry about our entire 
social fabric. 
Our motto, pro bono humani generis, has its most direct application 
in the discovery of health-saving, death-combating knowledge. Its 
most obvious exemplification is in clinical research applied to the 
development of drugs and vaccines. But these publicly acclaimed 
advances are not the products of a static, stereotyped system of 
preplanned discovery and invention. They are the fruits of a multi­
dimensional, dynamically changing structure-the complex tissue of 
health science and technology. Health progress must be informed by 
scientific insights from an unpredictable variety of fields, and then 
sometimes it leaps forward by purely empirical discovery. The basic 
sciences have their own dynamics and are often energized by new 
puzzles from the world of practice. 
I am often asked whether the renewed consolidation of our 
institutional identity with health research means that every professor 
should make an immediate contribution to health applications. "No," 
I must reply, "that would soon be self-defeating." But we must design 
and maintain an institutional structure that as a whole will make the 
most effective contribution to both the underlying basic sciences and 
their applied fruits. Each new appointment should be scrutinized for 
its contribution to our collegial effort. In bringing a person here, we 
should ask whether there is an advantage to the institution's entire 
program that would socially justify the stresses and costs of moving 
people from place to place. The excellence of a scientific work viewed 
in isolation is thus an important, but not an exclusive, criterion. 
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As I have already noted, most of the nation's larger, more complex 
institutions-in order to reconcile the conflicting demands of their 
established constituencies-find it difficult or impossible to identify 
their fundamental goals and to design evolutionary structural changes 
that will make them functionally most effective in meeting their own 
aspirations. The Rockefeller University is a uniquely modern insti­
tution, in that it was thoughtfully and consciously designed at its 
inception and redesigned, with equal care, at several historic transition 
points. It is true that in adopting the title University, the institution 
ran some risk of simply inheriting a trunkful of traditions rooted in 
the history of academic life generally, not all of which are pertinent 
to its own goals and capabilities. But an advantage deriving from the 
change is that our students and faculty have better access to the 
mainstreams of career opportunities and, in turn, we can more readily 
recruit from external sources. Since 1901, partly because of the 
inspiration supplied by the success of The Rockefeller Institute, 
biomedical research has grown enormously, and we cannot afford to 
be isolated from the extensive efforts being made at many other kinds 
of institutions throughout the world. 
From time to time, the question has been posed, quite correctly: 
In the light of the overall growth of research capability, what now is 
the special role of The Rockefeller University? The manifest answer 
is, as it has always been, the standard of excellence set by its faculty 
and students. To continue to meet that standard requires a flow of 
public and private resources that entails unremitting struggle to 
sustain. To justify that flow requires a vision of inspiration and 
organization, a design to meet the goal of the advancement of science 
for health. 
The main elements of scientific direction are, on the one hand, the 
identification of research opportunities and of the superlative individ­
ual competence needed to exploit them. On the other hand, there are 
the institutional responsibilities for nurturing that competence, both 
materially and morally, and for facilitating the mutual criticism, 
communication, and collaboration that make an institution more than 
a "boarding house of scholars." With respect to both of these elements, 
I repeat that our present institutional structure offers a unique oppor­
tunity for leadership. We are less encumbered than any comparable 
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organization in the capacity for self-management and adaptive 
change, after thoughtful consideration, to improve the efficiency and 
efficacy of scientific research. Since the beginning of the century, the 
fruit has been a continuing harvest of the most consequential and 
highly regarde.d discoveries, impressive in absolute terms, and surely 
preeminent in the yield per dollar invested. 
At the present time, the flow of federal funds for the support of 
research is essentially at a plateau, but an enormous one-so large as 
to have discouraged the private sector from sharing in the support of 
Messenger ribonucleic acid (mRNA) is the 
information carrier that transmits the mes­
sages encoded in the cell's genetic data 
bank, deoxyribonucleic acid (DNA). The 
messages instruct the cell's machinery to 
make - in the amount needed, when 
needed - the proteins basic to all life 
processes. But how is a particular message, 
stored in one of the thousands of genes 
which constitute an organism's master 
code, "expressed" precisely when re­
quired? What switches genes on and off? 
Scientists have made great progess in 
understanding the mechanism of gene 
expression in bacteria. The DNA in a bac­
terial cell (prokaryote) is not bound within 
a nuclear membrane, as is the DNA in the 
eukaryotic ("true nucleus") cells of hu­
mans and other higher organisms. In bac­
teria, the transcription of a genetic mes­
sage into a molecule of RNA, followed by 
conversion into a protein, is a direct proc­
ess. The primary RNA transcript, or copy, 
is the messenger RNA. As soon as the new 
RNA molecule begins to be transcribed, it 
is engaged by cell organelles called ribo­
somes, which then begin to make protein. 
Not so, scientists have found, when it 
comes to gene expression in the larger and 
more complex eukaryotic cell. Only re­
cently have molecular biologists begun to 
identify the steps in the intricate process 
by which eukaryotes make messenger 
RNA, a key event in normal and abnormal 
cell growth. 
Years ago it was found that DNA in 
eukaryotic cells produces RNA molecules 
substantially larger than messenger RNA. 
James E. Darnell, Jr., a Vincent Astor Pro­
fessor at the University, and his associates 
have spent more than 15 years deciphering 
the meaning of these large nuclear RNA 
molecules. Their experiments have pro­
vided much of the evidence for the surpris­
ing conclusion that the large RNA mole­
cules in the cell nucleus are the precursors 
of smaller messenger RNA molecules in 
the cell cytoplasm. The primary RNA tran­
script of the DNA code in the nucleus of 
the eukaryotic cell is not used directly as 
mRNA. Instead, the long, ribbon-like pre­
cursor molecules are cut - by enzymes 
- into smaller pieces that undergo certain
chemical modifications. Then, as shown in
the diagram, some of these RNA segments
are spliced together to form messenger
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experimental laboratory research. Ever-increasing burea!lcratic har­
assments aside, it is true that federal funds can be obtained for a wide 
variety of specialized projects. But this government support is pri­
marily for categorical disease-related research. What is often neglected 
in federal funding is the need for continuity in long-range research 
programs and their meaningful integration into an institutional effort. 
RNA, which directs protein production in 
the cytoplasm. 
define in biochemical terms how and at 
what level gene expression is regulated in 
humans and animals. Beyond that lies one 
of the prime goals of biological science 
today - the regulation of cancer cells. 
This new understanding of mRNA for­





The differences between messenger­
RNA formation in prokaryotes and in eu­
karyotes also has profound implications 
for the study of evolutionary biology. It 
has been assumed by many that eukary­
otes evolved from prokaryotes. But the 
findings of Dr. Darnell and others strongly 
indicate that a simple sequential evolution 
of eukaryotes from organisms like today's 
bacteria did not occur. If this is true, Dr. 
Darnell suggests, "then it seems not only 
possible but logical that the basic rules of 
genome organization might also differ be­
tween present-day prokaryotes and eu­
karyotes." (The genome is the complete set 
of hereditary factors encoded in the cell's 
DNA.) 
All of this may have an important 
bearing on future research. Dr. Darnell 
concludes, "If the molecular basis of eu­
karyotic gene regulation is to be_ explained 
in relation to developmental biology or 
cancer biology or endocrinology or many 
other topics, it is at least possible that we 
cannot rely on bacterial models but must 
again solve the molecular control mecha­
nisms of eukaryotic genes." 
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This is compounded by th� innumerable, subtle counter-incentives 
that constantly chip away at that integration. Private support is thus 
both indispensable and a means of leverage. By assuring the conti­
nuity and the integration essential to productive research, such sup­
port can assure the most creative utilization of the federal monies that 
constitute almost half of our operating budget. This ratio is appropri­
ate; there would be great perils if it were to increase substantially. 
In the years ahead, it will be one of my central responsibilities to 
reexamine the roots of scientific creativity. I have no easy prescription 
for fostering such creativity. In my own experience, however, nothing 
equals the confrontation of an eager, trained curiosity with the 
established doctrines and with the new findings of other disciplines. 
In such fresh encounters, new questions arise. The traditions and 
structures of our University off er unexcelled examples and new 
opportunities for this kind of discourse; but there is still much to do 
to bring this approach to its fulfillment. We may even have lost 
ground in recent years because of the expansion of the campus and 
the disappearance of the venerable Welch Hall dining room, which 
furnished such a congenial setting for interdisciplinary exchanges. To 
find a creative functional heir to that tradition is one of my immediate 
preoccupations. 
Contemporary Challenges in Health Research 
In 1901, bacterial infections-the great plagues-were the most 
serious challenges to health. Following on the work of Pasteur and 
Koch, the Institute was an important encampment of "The Microbe 
Hunters," so called by Paul de Kruif in a book that inspired a 
generation of medical scientists (including myself). Developments in 
sanitation, vaccines, antibiotics, and nutrition have given our people 
the most startling improvement in public health experienced in his­
tory, and those diseases no longer top our list of concerns. But these 
same successes have raised public expectation to a level almost 
impossible to satisfy in other fields, although the development of 
vaccines for the important killer viruses has been a major accomplish­
ment of the last 25 years. 
Today, our public health concerns number heart disease, psychi­
atric disease, and cancer as the chief causes of severe disability and 
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death, and other virus infections and degenerative diseases, such as 
arthritis, as grave hindrances to a happy life expectancy and produc­
tive employment. The hunting of microbes was a relatively easy 
task-the villain was a well-definable alien species. We had but to 
track and kill it, or at least check its spread. For today's major health 
threats, the problem is lodged within our own bodies. We face the 
subtle challenge both of achieving a deeper understanding of the 
human organism, far more complex than any bacterium, and of 
refining the very process of research involving human beings to 
change our own physiology in order to improve our health. Of course, 
we generate many health problems through our individual life styles. 
The issues of diet, exercise, smoking, and alcoholism are too familiar 
to bear repetition. Even so, we do not properly understand the 
mechanisms or precise efficacy of changes of life style as they affect 
health, and the very accomplishment of more hygienic styles of living 
is a challenge to the behavioral sciences. 
There is no lack of challenge to physiology, either. We really do 
not understand at all the perceived gratification that leads people to 
smoke, and we may well be on the wrong track in popular myths 
about the drives in alcoholism. Studies of the mechanism of action of 
opiates on the brain have just recently excited an explosion of 
discovery of previously unsuspected natural drugs in the brain, such 
as the endorphins, that may also be the key to many other psychiatric 
problems. The abysmal failure of most attempts to alter bad habits of 
excessive eating, drinking, and smoking tells us that to have a real 
impact on public health via "life style" will take a far more sophisti­
cated insight into human behavior than moralizing about what is bad 
for you. 
Prevention of disease is surely our primary objective for today's 
most serious health problems, simply because it is so difficult to effect 
useful remediation of the human body once its parts have begun to 
fail. Many specific environmental influences are now suspect in heart 
disease and cancer, and a clearer delineation of the hazards to avoid 
and of the specific dietary intake to encourage will add a badly 
needed precision and efficacy to life-style admonitions. As I will 
discuss in more detail further on, we also need more precise attention 
to risk-assessment of chemical hazards in the environment to provide 
credible direction to overarching policy choices in environmental 
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regulation, which otherwise may paralyze the national economy. In 
all likelihood, basic research will be even more cogent for these 
questions than for the design of new means of diagnosis and treatment 
of existing disease. 
Besides the ,specific mechanisms of arterial disease or cancer, the 
more general condition of aging points to the most fundamental 
biological questions-why, for instance, are the life-spans of man 
and mouse so different?-that touch upon the gravest aspects of the 
human condition. To pursue these questions will require intense and 
sophisticated interweaving of basic and clinical pursuits. 
Research Priorities 
At this University, it is important that we maintain ourselves at the 
forefront of basic research in molecular and cell biology: those 
fundamental areas of chemistry that are most closely connected with 
understanding the structure and function of cells and the higher levels 
of organization of molecules into cells, tissues, organs, and organisms. 
We must also continue to explore the connections between behavior­
animal and human -and the knowledge gained from studies at the 
molecular and cellular level. It is a short step from this kind of science 
to practice. We are becoming increasingly aware, for example, that 
such basic biological mechanisms as communication between cells 
and hormonal function must be better understood before we can deal 
effectively with the crushing practical problems associated with global 
human reproduction. 
The University has a very strong record of significant contribu­
tions to the field of parasitology, particularly in the understanding of 
malaria and other major tropical diseases. (Some of this research is 
reviewed on page 15.) Parasitic infections constitute the greatest 
health problems in vast areas of the world. To sustain the strong 
research base we have for meeting this challenge and to energize it 
with the insights of molecular biology are concerns central to the 
University's mission. 
Tremendous opportunities have arisen in the last several years for 
work that has a base in molecular biology on one side, involves 
behavioral science on another, and can contribute directly to solving 
the urgent problems of psychiatric illness. The University must follow 
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up on these opportumties and recruit people who respond to the 
potentialities of such broadly based research. 
The reciprocal dependence of health research and clinical man­
agement of disease is mirrored in the techno-political problems we 
face in sustaining a healthy environment for our species. An expand­
ing industrial society today inevitably spews out an unprecedented 
volume and variety of new substances to which we are exposed in air, 
water, foods, drugs, at the work place, and at home. Each such 
product, whether a natural compound like nitrate or a synthetic 
innovation like saccharin, poses an intricate scientific problem. What 
are the laboratory tests that will enable us to predict the toxicity to 
man of a given substance? And such knowledge would still be far 
from providing the framework for deciding how much of a given 
toxic exposure is an acceptable trade-off for an economic and social 
benefit. We have only a handful of people who are even able to 
communicate intelligently in the languages-scientific, technical, 
economic, political--- used on each side of the discourse. There has 
been a grave failure in our educational institutions in that they have 
not grappled with how to educate more people to cope properly with 
these kinds of issues. 
The Rockefeller University would certainly be an ideal setting in 
which to institutionalize the discipline of comparative toxicology, 
which is the scientific approach to these problems. That is, how can 
we use laboratory data on other species and field observations on 
sample populations to predict and assess risks to a wider consuming 
public? Such studies call upon all that we know of human genetics 
and evolution, particularly with respect to comparative biochemistry 
and physiology. They will require the use of the most sophisticated 
techniques of analytical chemistry and studies of the metabolism of 
particular substances in man. 
The articulation of this new science with policy may demand more 
far-reaching steps. In the end, political decisions will have to be made 
involving participatory processes that are beyond the special ken of 
the University. Nevertheless, we still have an important responsibility 
to voice the consequences of alternative policy choices, applying the 
best technique of rational analysis that we can muster. The viability 
of an industrial economy, as well as our personal security as individ-
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uals exposed to environmental threats, is at peril in these public policy 
choices. 
In approaching the trade-offs to toxicity-which are inexorable 
because the very act of breathing pollutes the environment-we need 
new institutions where the academy can work more closely with 
government, with private foundations, and with industry. Exploring 
the most useful forms of such collaborations, particularly to exploit 
the existing resources and respond to the needs of the metropolis, has 
been an urgent and ongoing preoccupation for me. 
The Outlook for Clinical Research 
Before leaving the topic of research priorities, I would like to comment 
on our Clinical Research Center, The Rockefeller University Hospi­
tal. Since its creation in 1910, the Hospital has been an integral part 
of this institution. The recent competitive renewal of the major clinical 
research grant from the federal government attested to the great 
national importance of the Hospital's programs, which span a wide 
Thr�e years ago, William Trager, head of 
the University's parasitology laboratory, 
and James B. Jensen announced the first 
continuous cultivation in a test tube of 
Plasmodium falciparum, the parasite of 
human malaria. This achievement-which 
freed malaria research from its depend­
ence on limited samples from human in­
fections or on· the availability of owl mon­
keys, the only suitable laboratory hosts­
eliminated a major obstacle to scientists 
seeking a vaccine against the disease that 
claims more victims and lives around the 
world than any other. 
The culture method has now been ap­
plied successfully to several parasite 
strains from different geographical areas 
and has also been used for tests of anti­
malarial drugs. Most significantly, the dis­
covery has made possible a broad new 
range of biochemical and immunological 
investigations by Dr. Trager and his col­
leagues, and by investigators elsewhere 
who are working against the background 
of an alarming resurgence of malaria, par­
ticularly in tropical and subtropical areas. 
A good deal of this research is funded by 
such agencies as the World Health Orga­
nization, the National Institutes of Health, 
and the U. S. Agency for International 
Development. Doctors Trager, Jensen, and 
Robert T. Reese have devoted considerable 
time and effort to helping other laborato­
ries - particularly in Asia, Africa, and 
Latin America - to initiate and maintain 
cultures of P. falciparum. 
One of the most promising lines of re­
search opened by the availability of con­
tinuous culture techniques is related to the 
protrusions that develop on the outer 
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array of research efforts in the study of human diseases. More than 
30 well-defined disorders, largely chronic and degenerative in nature, 
are under investigation. Overall, they represent a major portion of 
the disabling and lethal afflictions to which human beings are subject 
and for which we have yet to find wholly satisfactory means of 
prevention and treatment. Working with the senior faculty, adminis­
tration, and trustees, the Hospital's physician-in-chief, Dr. Attallah 
Kappas, bears principal responsibility for appraising opportunities 
for new research initiatives that will enhance the strengths of this 
superb facility. 
We are facing some redefinition of what constitutes clinical re­
search these days. There was a time when the observation of disease 
at the bedside was, by itself, a very important part of medical progress. 
The clinical scientist still relies on direct contact with individual 
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patients, but more and more of the studies central to clinical research 
are done on tissue and fluid samples. This requires seeing patients for 
short intervals, rather than being directly engaged with them over a 
very long period of time. Such an approach has important practical 
implications for our Clinical Research Center that we are just begin­
ning to explore in detail. 
The Hospital has always been noted for a broad range oflabora­
tory research that has complemented direct work with patients. Today, 
more than ever, we are seeing the Hospital as a base for research 
projects-involving human subjects-a very large measure of which 
is not done in an immediate clinical context. You might describe the 
Hospital as the summit of an iceberg of research that reaches deep 
into basic science. For example, in research on diabetes and other 
diseases, the investigators obtain samples from patients and carry out 
membranes of red blood cells (erythro­
cytes) infected with the human malaria 
parasite. These "knobs" (visible in electron 
micrographs, like the one shown here, as 
inverted, cuplike plaques just beneath the 
membranes) occur only in erythrocytes 
harboring older parasites and are the por­
tions of the infected cells that adhere to 
the endothelial cells of the capillaries 
imbedded in the heart and other organs, 
where the disease takes hold. By chemical 
and immunological studies, Dr. Araxie Ki­
lejian showed that the material in the 
knobs is antigenically distinct from normal 
red-cell membranes and is clearly of par­
asitic origin. Susan G. Langreth and Dr. 
Reese then discovered that owl monkeys 
made immune to falciparum malaria pro­
duce antibodies to the knobs. Most re­
cently, Dr. Langreth has made the intrigu­
ing discovery that each of three different 
strains of the human parasite that had 
been in continuous culture between one 
and two years developed variants that do 
not form knobs in the erythrocytes they 
infect. This was the first report of a change 
in P. falciparum after extended test-tube 
culture. 
Work is now in progress to determine 
the relative disease-producing potential 
(pathogenicity) of "knobless" and 
"knobby" lines of the human malaria par­
asite. Does knoblessness reflect a change 
in the pathogenicity of the parasite, which 
can be tested in experimental animals? Do 
other changes as yet undetected occur in 
the parasites after extended cultivation? 
The investigators do not yet have the an­
swers. However, they do know that the 
answers will be especially relevant to re­
search on possible malarial vaccines and 
to drug screening and chemotherapy. 
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some protracted observations of individual patients, but_ spend most 
of their time in the laboratory testing biochemical approaches to the 
treatment of disease. This is, in part, a result of new developments in 
scientific technique. If you can maintain human cells in the test tube, 
you can test the effects of chemicals on these cultures, rather than 
within a patient. 
Since we need a certain minimum scale of activity for efficient 
operation of the Hospital, we are also actively engaging the interests 
of neighboring institutions in clinically related studies. We are happily 
situated in a neighborhood of medical institutions-The New York 
Hospital and Cornell University Medical College, the Sloan-Kettering 
Institute for Cancer Research and Memorial Hospital for Cancer and 
Allied Diseases-and have numerous possibilities for matching our 
own intellectual style and skills in research to the diverse problems 
and resources of our neighbors. This framework of cooperation means 
our investigators can undertake collaborative work at these larger 
hospitals with their highly advanced technology for patient care. In 
return, their staffs will have access to the different technical resources 
of our Clinical Rese�rch Center and to the, in some respects, more 
efficient and closer surveillance of patients it makes possible. This 
growing collaborative effort is of particular value in guiding the 
research and education of some of our younger scientists who hold 
clinical research fellowships. It gives them a much wider variety of 
experience than they would encounter within our Hospital alone. In 
like fashion, our proximity to the Payne Whitney Psychiatric Clinic 
at The New York Hospital has given us the opportunity to explore a 
range of options that will further research on the biochemical aspects 
of schizophrenia, depression, and other psychiatric disturbances. 
Postdoctoral Training 
This brings me to the University's traditional educational role-the 
support and preparation of gifted young people for scientific careers. 
From the very beginning , this institution has functioned as a focal 
point for individuals from all over the world who are seeking to 
deepen their experience in research by working side by side with 
senior colleagues who are recognized leaders in their fields. Thousands 
of gifted investigators have passed through our laboratories and have 
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moved on to important rese�rch posts in other institutions. Many of 
them return from time to time to share with former colleagues the 
fruits of their own investigations or to carry out some collaborative 
project in one of our laboratories. The impact of this continuing 
venture in postdoctoral education on the quality of biomedical science 
in this country is one of the University's major distinctions. It is a 
fulfillment of the hopes expressed at its founding, at a time when 
aspiring scientists had to seek their training in institutions abroad. 
Everything I have said about the structure and style of the 
University with regard to research applies to its educational activity. 
The younger scientist taking his first step in a research career is 
received as a colleague in every sense of the word, and is free to move 
beyond his own laboratory to seek whatever advice or guidance he 
needs in building his own base of knowledge and research expertise. 
Graduate Study Program 
This is, to a large extent, equally true of our graduate program. A 
memorable experience that capped my first year in office was par­
ticipating on June 6, 1979, in the awarding of the Ph.D. degree to 28 
graduates. This was the University's 21st Convocation and the 25th 
anniversary of its assuming the status of a graduate university. 
Having recently attended convocations with audiences in the tens 
of thousands, I was impressed by the focus on individual talent and 
performance that dominated our modest ceremony. We were able to 
present each candidate and review very personally his or her accom­
plishments and high promise. There is no doubt that these people will 
be the leaders of medical science, and that each one has the chance 
to reshape the way in which we view the world and how we adapt to 
live in it. Nothing could better exemplify the special quality of this 
institution. 
Operationally, the graduate program takes advantage of the exist­
ing edifice of the research institute. The students enter a flexible 
tutorial program that encourages initiative on their part and places a 
heavy emphasis on research experience, which the University is so 
uniquely structured to provide. 
All of us- and Dean James G. Hirsch and his associates in 
particular-put a great deal of time and expense into student selec-
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tion. By bringing applicants to the campus, we can see them as 
individuals and evaluate their maturity and creativity. The very low 
dropout rate (about 5 percent) justifies the effort. In a closely knit 
campus community with a strong sense of common goals, the impact 
of I 00 brilliant young people from all over 'the world is provocative 
in the highest sense, both intellectually and socially. 
After just a quarter of a century, the University is justified in 
viewing its educational "experiment" as successful in its objective of 
producing leaders in science. This is indicated by the outstanding 
recognition given to it by scientists and educators throughout the 
world, as well as by the results of independent national evaluations of 
the quality of doctoral graduates in the biomedical sciences, all of 
which place the University's alumni at the top. 
Equally impressive are the accomplishments of our alumni. Of 
The skin is the largest organ of the human 
body, accounting for three to five percent 
of its total weight. Because this cutaneous 
tissue is a remarkably resistant and tough, 
yet pliable, membrane, we tend to view it 
primarily as a passive barrier that blocks 
harmful materials from entering the body 
and prevents essential body substances 
from escaping. But increasing concern 
about the possible toxic effects on human 
beings of many chemicals in the environ­
ment has focused increased scientific re­
search on structures, like the skin, that 
function at the interface of the body and 
the world around it. 
One of the scientists contributing to 
this research is Attallah Kappas, physi­
cian-in-chief of The Rockefeller University 
Hospital and head of the metabolism­
pharmacology laboratory. A major inter­
est of the laboratory is environmental bio­
medicine, particularly clinical studies of 
human disorders caused by drugs and en­
vironmental chemicals. Research by Dr. 
Kappas and David Bickers, formerly a 
Rockefeller University Scholar in Clinical 
Sciences and presently chairman of the 
Department of Dermatology at the Case 
Western University School of Medicine, 
on coal-tar products and cutaneous tissue 
suggests the import of recent findings on 
the role of the skin. 
Coal tar, a by-product of the gasifica­
tion and distillation of coal, is widely used 
in the treatment of dermatologic diseases, 
particularly such chronic skin disorders as 
eczematous dermatitis and psoriasis. Coal 
tar contains a number of chemicals called 
polycyclic aromatic hydrocarbons, includ­
ing 3, 4-benzo [a]pyrene (BP). BP is a pre­
cursor of several potent chemical carcino­
gens found in the environment; it is known 
to evoke tumors in the skin of experimen­
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325 graduates surveyed in the summer of 1978, 76 (23 percent) had 
reached the rank of full professor or the equivalent, 85 (26 percent) 
were associate professors, and another 26 percent had become assist­
ant professors. About 95 percent of all graduates were engaged in 
full-time research and teaching. Two graduates have won the Nobel 
Prize. In reading these figures, one should bear in mind that our 
alumni are, on the average, only a decade beyond completion of their 
graduate work. 
I strongly agree with the well-established policies of our graduate 
program-that it should continue to operate according to the prin­
ciples and scale that have governed it from the start. Our most 
pressing needs for educational innovation relate to the integration of 
scientific and medical interests. Our current response to this concern 
is the joint M.D./Ph.D. program with Cornell University Medical 
4 5 
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Coal-tar solution was applied to the skin and 24 hours later 
the site was biopsied. Skin homogenate was prepared and 
AHH activity determined. 
Studies in experimental animals suggest 
that aryl hydrocarbon hydroxylase 
(AHH), an enzyme present in skin, plays 
an important role in metabolizing (chemi­
cally transforming) polycyclic hydrocar­
bons like BP into intermediate substances 
that may directly trigger cancer. Dr. Kap­
pas and his colleagues had demonstrated 
earlier that AHH is present in the skin of 
newborn human beings, and that enzy­
matic activity is considerably increased by 
the process of enzymatic induction when 
cutaneous tissue is incubated in cultures 
with a polycyclic hydrocarbon, such as 
benzanthracene. With all this as a back­
ground, Doctors Kappas and Bickers 
thought it important to assess the AHH 
induction effect of coal tar on patients 
undergoing treatment for chronic skin dis­
orders, for which this widely used drug is 
employed. 
Their studies showed, for the first time, 
that the application of a coal-tar prepara-
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College, launched in 1972. This program is designed for a small group 
of candidates who are strongly motivated toward a research career in 
the basic or clinical biomedical sciences. The first Ph.D. degree in 
this program was awarded in 1977, so a definitive evaluation is still 
some time off, but the sheer quality of our registrants is a guarantee 
of success. One objective indication is that this program was one of 
the very few to get a renewal from the National Institutes of Health 
with substantially full funding of our request. This gives us the time 
to undertake a critical examination of the basic educational goals of 
the effort and to seek approaches that will assure the maximum return 
from the substantial investment of time and other resources. 
Responsibilities to Young Scientists 
The University seeks to provide a special place for the early devel­
opment of careers in science with the expectation that the people 
tion to the skin of patients with dermato­
logic diseases induced AHH activity in 
cutaneous tissue. This activity was from 
two to five times greater than the enzyme 
activity in untreated areas of the skin of 
the same individuals. Of the several coal­
tar constituents available for testing, BP 
had the most potent effect. In related test­
tube experiments, the investigators found 
that enhancement of AHH activity also 
took place when human skin was incu­
bated with coal-tar solutions. 
A third set of studies showed that use 
of coal tar on the skin of experimental 
animals causes induction of cutaneous 
AHH and, after absorption through the 
skin, also of AHH in the liver. Recent 
studies in humans confirm that when coal 
tar is applied to the skin, liver metabolism 
of drugs and other chemicals is altered 
substantially. 
The data reinforce prior evidence that 
human skin has enzymes capable of re­
sponding to environmental carcinogens 
and locally applied drugs and of convert­
ing them into reactive metabolic products. 
Doctors Kappas and Bickers conclude that 
such metabolic activity may be one of the 
important determinants of the pharmaco­
logical potency of many drugs. It may also 
be a critical factor in carcinogenic and 
toxic responses to environmental chemi­
cals, not only in the skin but also in other 
tissues, after percutaneous absorption. As 
more information about enzyme activity 
in the, skin accumulates, science may have 
to credit the body's largest organ with 
being a far more active part of its meta­
bolic machinery than traditional views 
suggest. 
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whom we have recruited wi�l find important research positions, not 
just jobs, elsewhere. But there have been many changes in the 
environment for science. We no longer live in an era where infinite 
growth is the implicit agenda. Problems with the overall level of 
science funding in this country, and the fact that only a small fraction 
of approved grant applications is actually funded, are very discour­
aging and tend to push people to aim for only safe targets. In fact, the 
academic market for most doctoral graduates has shrunk, as have the 
resources available for their training. This, in turn, reduces the 
mobility from one center to another that is so important for the 
vitality of science. 
Having undertaken the responsibility of a productive and trans­
forming role in dealing with scientific talent, we have to think very 
carefully about the careers of our people. At one level there is the 
eternal issue of quality control, to insure that the people we recruit 
warrant the investment entailed in simply having them here, and that 
they will make the most effective contribution to our research pro­
grams. We also have to be careful about justice to them, primarily in 
being sure that they are fully aware of what the world is like, and 
what our own local world is like. We must plan with them the 
optimum timing of their entry and, for most of them, their departure 
at times and in ways most appropriate to their career development. 
That very few long-term positions become available and that these 
are likely to be filled on the basis of a national search has always 
prevailed here, whereas at many other institutions it has become a 
reality fairly recently. What we owe our young fellows and faculty is 
an adequate opportunity to prove themselves and to develop their 
own capabilities and intellects to the point at which they can further 
their research objectives. Wherever appropriate, we foster indepen­
dence to assure that their work is fundable by indispensable research 
grants at the time they move to other positions. 
Material Resources 
To this point, my report has focused on the importance of our work 
and the task of communicating and shaping that work to the best 
interests of the human purposes we ultimately serve. But there is a 
complementary task-a material one-of matching our plans and 
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operations to a realistic model of the resources available. 
The concept of collegial effort, pro bono humani generis, was 
basic to the motivation of the Institute's founder. In 1901, John D. 
Rockefeller, Sr. provided the financial base, which, with subsequent 
additions from other family sources, enab,led it to operate entirely 
from endowment income until the 1950s. By the early 1970s, however, 
it became evident that the scope of the work of the University and its 
importance to society had grown beyond the point where it was either 
practical financially or appropriate in principle to depend on a limited 
base of private support. If the University is to continue in the forefront 
of the life sciences and as a major contributor to the improvement of 
the human condition, then it has the obligation to develop future 
support from an entirely new constituency of private donors. We can 
best earn the confidence of these prospective supporters by adhering 
to the core principles of this coherent research community. 
One other observation is pertinent in this connection. A glance at 
Chart 1, showing the sources of University income, reveals a steady 
increase in government grants since it was decided to seek outside 
funding. Such support is absolutely indispensable and, in fact, gov­
ernment grants account for almost half of our annual operating 
budget. However, as I noted earlier, it is predictable but lamentable 
that this level of federal involvement inescapably comes to be asso­
ciated with a frustrating degree of centralized management by the 
government. Much of this funding is aimed at the "purchase" of 
specified research results, neatly packaged in "projects." At its incep­
tion, the federal support of biomedical research, �dministered pri­
marily through the National Institutes of Health, reflected ideals 
similar to the University's and admirably supported major innova­
tions and discoveries. But the project grant system is now run in ways 
that, however well-intended, sometimes threaten to disintegrate insti­
tutions, to discourage the confluence of creative ideas, and to erect 
serious obstacles to the collaboration of basic scientists in a wide 
variety of clinical applications. 
In the long-term planning for the University's financial future, we 
cannot forget that one of the most important functions of a privately 
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services-rendered approach to research support. We have i? mind the 
investment of venture capital in the identification of creative individ­
uals and of collegial frameworks for reaching the same ends. The 
central ethos of this institution is the responsibility of making up our 
own minds-independent of erratic fluctuations in external attitudes 
and policy- about the areas that warrant careful nurturing and 
support, sometimes over fairly long periods. 
A Financial Projection 
In appraising the University's financial situation, I must affirm right 
at the start that we may congratulate ourselves in being far closer to 
equilibrium today than are most other private academic institutions. 
This is largely due to the foresight of my predecessor, Frederick Seitz, 
and the University Board of Trustees in husbanding the University's 
resources so carefully and launching the first fund-raising effort in 
our history. There has been a decade of effort to make the University 
fiscally stable and to preserve its distinction. The most painful ad­
justments are already behind us. These have included a significant 
reduction in non-faculty staff from a peak of 1,033 in 1971 to slightly 
more than 890; a leveling-off in both tenured and non-tenured faculty 
at about 450 after an almost threefold growth since 1955; a concerted 
effort to hold down costs; and an ongoing process of reexamining 
institutional priorities. 
With hard work and moderate good luck, we have a planning 
framework for vigorous survival. We have already brought our cur­
rent expenses budget into balance (Table 1), and we are projecting a 
balanced overall budget (including capital expenses) within a few 
years. But, as Chairman of the Board Patrick E. Haggerty has stressed, 
this projection is based on the "conviction that fund-raising from 
diverse private and public sources must be an intensive continuing 
effort open to periodic adjustment of goals. The University has faced 
up to the reality of the times-that to maintain its high level of 
achievement, it must sustain indefinitely the effort of the past decade 
to attain greater financial independence." 
Before exploring more fully the scope of our fund-raising com­
mitment, I think it is necessary to answer a question that may be 
prompted by the picture I have presented of an institution that is 
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consolidating its goals and stabilizing its growth in size and numbers. 
"Why do you need more money if your policy is to hold to ihe present 
size of the University?" There are two answers to this question: one 
to be found in an analysis of where our money goes and the other in 
a statement of our basic endowment needs. , 
Where the Money Goes 
A glance at Chart 2 shows that 65 percent of our current expense 
dollars are direct expenditures for our research and education pro­
grams. That is as it should be, because we are really talking about the 
support of first-class scientific work by people of the highest caliber. 
The fact is that a certain amount of renovative growth has to be built 
into such a community to sustain vitality. Even though we do not 
plan to increase the number of full professors, an inherent growth of 
"technicality" at this University is related to the complexity of the 
equipment we use and the sophistication of the work we do. This is 
not numerical growth, but it is definitely a cost growth. Similarly, in 
an institution where there is a constant coming and going of investi­
gators, particularly at the non-tenured rank, we need the resources to 
regenerate the system constantly, even though, over the course of 
time, there are no major fluctuations in the overall scientific popula­
tion. 
A related figure in Chart 2 is the 13 percent that the University 
expends for the operation and maintenance of its physical plant. Over 
half of this amount is spent for energy. It is inherent in an institution 
such as ours to be energy-intensive for the operation of instruments, 
to keep laboratories working around the clock. Controlled environ­
ments, which require high usage of energy, are mandated by govern­
ment regulations/as well as necessary for stable results in experiments 
with animals. With the onset of the fuel crisis, the impact of energy 
costs has been increasingly aggravated and, even as I write, threatens 
to upset budget balances. 
Strengthening Endowment 
The energy problem is also involved in the second answer to our 
question about financial needs-we need additional resources to 
repair the depredations of our endowment. These stem from all the 
fiscal and economic blows we share with other non-profit institutions 
CHART 2 
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and that are built into the American economy, inflation�above all. 
For example, there was a small, absolute rise in endowment income 
from $8.9 million in 1969 to $11.4 million in 1979. However, this 
seeming improvement quickly fades if we consider that the income 
would have had to be _on the order of $15 million in 1979 to match 
the purchasing power of $8.9 million in 1969. Similarly, the market 
value of endowment funds in 1979 was over $201 million, approxi­
mately the same as in 1969. But to match the purchasing power that 
$201 million had in 1969, our endowment today would have to be 
over $350 million. 
As I have already indicated, though not discounting the very real 
threat of the unforeseeable, we can look ahead to achieving financial 
balance in the near future. We have made carefully considered 
projections, and we �pdate them on both quarterly and annual 
schedules to measure our performance against our goals. But the 
projections for a decade are sensitive to a number of assumptions that 
only the march of events can validate. 
Grant from the Rockefeller Brothers Fund
The best financial news of this academic year is that the University 
has been awarded a five-year grant of $15 million by the Rockefeller 
Brothers Fund, with future provision for an additional $7 .5 million if 
certain conditions are met. Without this generous contribution, in 
response to a comprehensive plan submitted by Dr. Seitz in October 
of 1977, it would be extremely difficult to foresee a balanced budget. 
The unrestricted grant of $15 million has betn allocated to the 
University's capital endowment. To receive the challenge grant of an 
additional $7 .5 million, the University must satisfy two conditions by 
December 31, 1986. The first is that the institution raise $10 million 
in new endowment in addition to the RBF basic award of $15 million. 
The second is that we match the additional $7 .5 million fund, dollar 
for dollar, by contributions to endowment from other private sources. 
The RBF has also stipulated that funds, estimated at about 
$500,000 annually, will be available to the University, Memorial 
Sloan-Kettering Cancer Center, and The New York Hospital-Cornell 
Medical Center for joint or cooperative projects initiated between this 
year and the end of 1983. I believe this is a highly constructive 
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mechanism for financing a number of worthwhile interinstitutional 
ventures, and a joint steering committee is working hard on tangible 
proposals. 
In fulfilling its special responsibilities to one of the organizations 
that historically has been of strong interest to the Rockefeller family, 
the RBF indicated that it contemplates making no additional large 
capital grants to the University. This does not preclude the future 
consideration of project requests in the light of the Fund's evolving 
program interests. 
We are all indebted to the RBF for this inspirational demonstra­
tion of faith in the future of The Rockefeller University as a major 
source of scientific innovation and medical progress. As magnificent 
as the grant is, we know it does not solve all our financial problems. 
However, the RBF award will serve as the cornerstone of a new and 
intensive plan, which responds to the challenge and calls for raising 
a total of $150 million from private sources within the next ten years. 
The new plan-shown here in summary form (Table 2)-incorpo­
rates all of the University's prime objectives, and aims to achieve 
them before the end of the next decade. A significant component of 
this plan is the University Associates Program, which will be instituted 
in 1979-80. This replaces and expands the current Annual Giving 
Program. It will broaden the base of constituency support for our 
annual operating expenditures. 
The task before us is not to be taken lightly. But we have a 
-�ompelling message and a sound plan to communicate to prospective
supporters, and the confidence that comes from knowing we are
proposing investment in an enterprise that has always been productive
of public good.
An Afternoon to Remember 
This has been a hectic year, a rewarding year, a full year. Even in so 
short a time I have many rich memories of this unusual community 
of which my family and I are now enthusiastic citizens. And we are 
deeply impressed by the spirit of cooperation and the individual 
concern shown by all members of the staff, whatever their area of 
responsibility. 
In closing this report, I would like to look back on one event that 
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had deep personal meaning _for me, both as a scientist and a "fresh­
man" president. On the afternoon of February 2, 1979, a seminar was 
held in Caspary Auditorium that drew a large audience from the 
campus, as well as scientists from a number of other institutions. The 
occasion was the 35th anniversary of the publication in The Journal 
of Experimental Medicine for February 1, 1944, of a paper by Oswald 
T. Avery, Colin M. MacLeod, and Maclyn McCarty on the chemical
composition of the "pneumococcus transforming factor." The trans­
forming factor, of course, was DNA, and the paper encapsulated
perhaps the most revolutionary biological discovery of this century_.:._
that DNA is the basis of heredity in all organisms.
Dr. Avery retired from The Rockefeller Institute for Medical 
Research in 1948 and died on February 20, 1955, in Nashville, 
Tennessee. Colin MacLeod served on the staff of The Rockefeller 
Institute from 1934 to 1941, then became a professor at New York 
University Medical School. He died on February 12, 1972, in London. 
Maclyn McCarty is now a John D. Rockefeller Jr. Professor at The 
Rockefeller University, having also served as vice president from 
1965 to 1978 and as physician-in-chief of The Rockefeller Hospital 
from 1960 to 1974. In fact, that February seminar was equally a 
celebration in his honor. 
Participating in the warm and spirited exchange of reminiscences 
that enlivened the gathering, I felt again the excitement with which­
as a new graduate of Columbia College venturing into research - I 
first read that now-historic paper and sensed its unlimited implica­
tions. It was the initiating impulse to my own scientific career. How 
gratifying then, 35 years later, to be among my peers in this commu­
nity, with the opportunity to help sustain a tradition and a style of 
biomedical research that have no match. 
GIFTS AND GRANTS 
On behalf of our faculty, graduate fel­
lows, and trustees, I would like to express 
our warmest thanks to the following do­
nors who have contributed to the Uni­
versity during the nine fiscal years since 
the first comprehensive effort in our his­
tory to broaden our base of private sup­
port was launched. 
The first list includes those donors 
whose assistance is helping to fulfill the 
goals of the University's overall Devel­
opment Program. Since its inception in 
1971, the Program's goals have empha­
sized additional endowment and long­
term operating support for basic research 
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in selected life sciences, for the clinical 
programs of our Hospital, for professor­
ships, and for predoctoral and postdoc­
toral fellows�ips. Several major donors 
also have aided the construction of our 
new Laboratory Animal Research Cen­
ter, a high-priority objective for which 
the remaining funds are still being 
sought. 
The second list recognizes contribu­
tors who have provided funds for general 
operating expenses, as well as for ongoing 
research and special University-wide 
projects. 
Donors to The Rockefeller University Development Program 
INDIVIDUALS 
Mr. Ralph E. Ablon 
Mrs. F. David Anderson 
Mrs. Vincent Astor 
Mrs. Wentworth Bacon 
Mr. and Mrs. Charles F. Barber 
Mr. Philip Bard 
Mr. Charles C. Bassine 
Mrs. Ursula Baum 
Mr. and Mrs. William Bernbach 
Mr. Nicholas F. Brady 
Mrs. Mabel Bright 
Mrs. Walker 0. Cain 
Mr. Ray F. Carmichael 
Mr. and Mrs. Eliot C. Clarke 
Mr. Clarence Coe 
Mr. C. W. Cook 
Mr. and Mrs. Donald C. Cook 
Ms. Jessie Corr 
Mr. Richard W. Courts 
Mrs. Virginia C. Courts 
Mr. and Mrs. Thomas G. Cousins, Jr. 
Mr. Michel David-Weill 
Eli Whitney Debevoise, Esq. 
Mr. and Mrs. J. Richardson Dilworth 
Mr. and Mrs. Barry W. Dress 
Dr. and Mrs. Rene Dubos 
In honor of Vincent du Vigneaud, M.D.
Anne E. Dyson, M.D.
Mr. Oscar Dystel 
Mr. and Mrs. Albert Foreman 
Mrs. Ann Haebler Frantz 
Friends of the University-Anonymous 
Dr. and Mrs. Harold Gershinowitz 
Friends of Elsie Gilenson 
Mr. and Mrs. William T. Golden 
Dr. Donald R. Griffin 
Mr. James Griffin 
Mr. and Mrs. Patrick E. Haggerty 
Mrs. Andrew Heiskell 
Mr. Leon Hess 
Mr. and Mrs. James T. Hill 
Mr. and Mrs. Robert C. Hubbard 
Mr. Denison B. Hull 
Mrs. Virginia S. Hutton 
Mrs. Lucretia Jephson 
Dr. and Mrs. Mark Kac 
Ms. Neva Kaiser 
Dr. Lindsley F. Kimball 
Mr. Bruce W. Knight, Jr. 
Mr. Fred F. Lester 
Mr. and Mrs. Budd Levinson 
Mrs. Tillie Lewis 
Marjorie Lewisohn, M.D.' 
Mr. and Mrs. John E. Lockwood 
Mr. and Mrs. Dan W. Lufkin 
Dr. and Mrs. Channing H. Lushbough 
Mr. Louis Marx 
Dr. and Mrs. Maclyn McCarty 
Dr. and Mrs. Neal E. Miller 
Mrs. Maurice Moore 
Mr. Albert L. Nickerson 
Mr. and Mrs. George D. O'Neill 
Dr. and Mrs. Carl Pfaffmann 
Mr. and Mrs. R. Watson Pomeroy 
Mr. David Rockefeller 
Mr. David Rockefeller, Jr. 
Mr. Walter N. Rothschild, Jr. 
Mr. Richard B. Salomon 
Mr. and Mrs. Howard Samuels 
Mr. Melvin R. Seiden 
Dr. and Mrs. Frederick Seitz 
Dr. Peter H. Sellers 
Mr. Peter J. Sharp 
Mr. and Mrs. Richard Shields 
Mr. and Mrs. William K. Simpson 
Mr. and Mrs. Herbert M. Singer 
Mrs. Mary Detweiler Smith 
Mr. and Mrs. James G. Stahlman 
Miss Jennifer Stone 
Mr. Robert G. Stone, Jr. 
Mr. and Mrs. Judson L. Streicher 
Mrs. Arthur Hays Sulzberger 
Mr. and Mrs. Henry L. U ghetta II 
Count and Countess W. A. W. van Limburg 
Stirum 
Mr. Robert L. Van Valer 
Mr. DeWitt Wallace 
Dr. W. Gordon Whaley 
Mr. Edwin C. Whitehead 
Dr. Eugene P. Wigner 
Mr. Alfred Wohl 
Mr. Lester Wolfe 
Mr. and Mrs. Sydney A. Woodd-Cahusac 
Ms. Catherine Levin Zaoujal 
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FOUNDATIONS 
Achievement Rewards for College Scientists 
(ARCS) Foundation, Inc. 
The Adler Foundation 
Rita Allen Foundation 
The Annenberg School of Communications 
The Vincent Astor Foundation 
The Robert and Ellen Bach Foundation, Inc. 
Baer Foundation, Inc. 
The Frederick W. Beinecke Fund 
Edith C. Blum Foundation 
Booth Ferris Foundation 
The Bernie Brown Foundation 
The Burroughs Wellcome Fund 
Carnegie Corporation of New York 
Mary Flagler Cary Charitable Trust 
Citizens Commission on Science, Law and 
the Food Supply 
Leo W. and Lilyan E. Cole Fund 
The Commonwealth Fund 
The Courts Foundation, Inc. 
Constans Culver Foundation 
The Arthur Vining Davis Foundations 
The Camille and Henry Dreyfus Foundation, Inc 
The Charles W. Engelhard Foundation 
The T. M. Evans Foundation 
Max C. Fleischmann Foundation 
The Ford Foundation 
Fribourg Foundation 
General Service Foundation 
Goldhirsch Foundation 
Herman Goldman Foundation 
William T. Grant Foundation, Inc. 
Susan Greenwall Foundation 
S. T. and Margaret D. Harris Foundation 
Charles Hayden Foundation 
Henry B Foundation 
Irma T. Hirschl Charitable Trust 
The Lillia Babbitt Hyde Foundation 
Jephson Educational Trust 
The Howard Johnson Foundation 
Kimmelman Foundation 
The David L. Klein, Jr. Memorial Foundation 
The Esther A. and Joseph Klingenstein Fund, Inc. 
The Bertha Koempel Foundation, Inc. 
The Kresge Foundation 
The Kroc Foundation 
Florina Lasker Charitable Trust 
The Lincoln Fund 
Mad River Foundation 
Brooks and Hope B. McCormick Foundation 
The McKnight Foundation 
Andrew W. Mellon Foundation 
Richard King Mellon Foundation 
Charles E. Merrill Trust 
The Andre and Bella Meyer Foundation, Inc. 
The Ambrose Monell Foundation 
Edward S. Moore Foundation, Inc. 
R. W. and Jane E. Olson Foundation 
William S. Paley Charitable Trusts 
The Perkin Fund 
Harold and Beatrice Renfield Foundation 
Fannie E. Rippel Foundation 
Rohanna Charitable Trust 
Rockefeller Brothers Fund 
The Rockefeller Foundation 
Billy Rose Foundation 
Samuel Rubin Foundation 
Scaife Family Charitable Trusts 
The Schiff Foundation 
The Lewis and Marcia Schott Foundation 
David Schwartz Foundation 
Seiden & deCuevas Foundation 
Gertrude Hochschild Sergievsky Trust 
The Shubert Foundation, Inc. 
Alfred P. Sloan Foundation 
The Spencer Foundation 
Gustav Stern Foundation, Inc. 
The Sulzberger Foundation, Inc. 
Surdna Foundation 
The Tubman Trust 
Tudor Foundation 
van Ameringen Foundation, Inc. 
Harry Winston Foundation, Inc. 
CORPORATIONS 
ALCOA Foundation 
Allis-Chalmers Foundation, Inc. 
American Telephone & Telegraph Company 
Amoco Foundation, Inc. 
Arthur Andersen and Co. 
Atlantic Richfield Foundation 
The Bache Corporation Foundation 
The Bowery Savings Bank 
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The Chase Manhattan Bank, N. A. 
China Investment and Trust Co.: Ltd. 
China Technical Consultant, Inc. 
Chong Tao Chemical Mfg. Co. 
Citibank 
Consolidated E,dison Company of New York, Inc. 
Corning Glass Works Foundation 
Deak-Perera Group 
Deloitte Haskins & Sells 
Engelhard Hanovia, Inc. 




General Public Utilities Corporation 
Gold Kist, Inc. 
Gulf Oil Foundation 





R. H. Macy & Co.
Marsh & McLennan Companies, Inc.
McKinsey & Co.
Merck & Co., Inc.
Merck Company Foundation
Metropolitan Life Insurance Co.
Milliken Foundation
Mobil Foundation, Inc.
Morgan Guaranty Trust Company
Foundation 
Morgan Stanley Foundation 
Motorola Foundation 
National Distillers and Chemical Corporation 
New York Life Insurance Co. 
New York Telephone Company 
The New York Times Foundation, Inc. 
Ogden American Corporation 
Organon, Inc. 
Pfizer, Inc. 
Philip Morris, Inc. 
The Prudential Insurance Company of America 
The Rapid-American Corporation 
R. J. Reynolds Industries, Inc. 
Rockwell International Corporation 
Squibb C9rporation 
Standard Oil Company of California 
Syntex Corporation 
Taiwan Cement Corporation 
Tandy Corporation 
Texaco, Inc. 
Texas Instruments Foundat,ion 
Union Pacific Foundation 
United Polymer Corporation 
United States Steel Foundation, Inc. 
USI Far East Corporation 
Wallace Murray Foundation 
Western Electric Fund 
Xerox Corporation 
GOVERNMENT CONSTRUCTION GRANT 
National Cancer Institute 
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BEQUESTS AND MEMORIAL FUNDS 
Estate of Aaron Becker 
Estate of Beatrice V. Bruyn 
Estate of Frederika Con 
Estate of Ernest F. Drew 
Estate of Lucia M. Drew 
Estate of Abby Rockefeller Mauze 
Estate of Viola B. Sharpley 
Estate of D. Branch Warwick 
In memory of Dr. Detlev W. Bronk 
In memory of John C. Eisenstein 
In memory of Dr. Philip D. McMaster 
In memory of A. W. Scheffres 
In memory of Jacqueline Susann 
In memory of Dr. Edward Tatum 
Governmental and Private Sources that Have Supported Ongoing Research 
Programs and Special Projects Through Gifts, Grants, and Contracts 
Agency for International Development 
American Cancer Society, Inc. 
American Chemical Society, Petroleum 
Research Fund 
American College of Physicians 
American Diabetes Association, Inc. 
American Heart Association 
American Society of Parasitologists 
App-Tax Consulting 
The Arthritis Foundation, Inc. 
A yerst Laboratories 
George F. Baker Trust 
Mr. Harry Baumgarten 
Biometric Testing, Inc. 
Bio Quest 
Cancer Research Institute 
Centre National de le Recherche Scientifique 
The Jane Coffin Childs Memorial Fund for 
Medical Research 
Ciba-Geigy Corporation 
Mr. Milton S. Cohn 
Katherine H. Cole Suggestion Fund 
The Conservation and Research Foundation 
Cooley's Anemia Blood & Research Foun-
dation for Children, Inc. 
AHEPA Cooley's Anemia Foundation 
Cooley's Anemia Volunteers, Inc. 
Cooper Laboratories 
The Council for Tobacco Research U.S.A., Inc. 
CPC International, Inc. 
Cystic Fibrosis Foundation 
Dairy Council of Metropolitan New York 
Deafness Research Foundation 
Deutsche F orschungsgemeinschaft 
Distilled Spirits Council of the United States, Inc. 
The Camille and Henry Dreyfus Foundation, Inc. 
E. I. du Pont de Nemours & Company, Inc.
European-American Bank & Trust Company
Mr. Harold L. Fierman
Fight for Sight, Inc.
The Ford Foundation
The Edward E. Ford Foundation
Foundation for Microbiology
Foundations' Fund for Research in
Psychiatry 
Henry Clay Frick II, M. D. 
Fulbright Commission 
The Honorable Stanley H. Fuld 
The Anna Fuller Fund 
Gannett Newspaper Foundation 
Dr. Walther F. Goebel 
The Herman and Ruth Goodman 
Foundation, Inc. 
The Harry Frank Guggenheim Foundation 
Heiser Fellowship Program for Research in 
Leprosy 
Hektoen Institute for Medical Research 
Herner Analytics, Inc. 
Hoffmann-LaRoche, Inc. 
Hoffmann-LaRoche Foundation 
Igaku-Shoin Medical Publishers, Inc. 
International Business Machines Corporation 
International Research and Exchange Board 
Mrs. Eleanor F. Jennings 
Alfred Jurzykowski Foundation 
Juvenile Diabetes Foundation 
Max Kade Foundation 
Mr. Joseph A. Kaplan 
Mr. Irving D. Karpas, Jr. 
John L. and Helen Kellogg Foundation 
The Mathilde and Arthur B. Krim 
Foundation, Inc. 
Mr. David B. Kriser 
Mrs. Grace L. Lambert 
Lasdon Foundation 
Leukemia Society of America, Inc. 
Dr. Philip Levine 
Life Sciences Foundation, Inc. 
The Lilly Research Laboratories 
Mr. Jack Linsky 
Lupus Erythematosus Foundation, Inc. 
Josiah Macy, Jr. Foundation 
Mr. Abraham L. Malamut 
Mr. and Mrs. David McAlpin 
Mead Johnson & Company 
The Medical Letter on Drugs & Therapeutics 
Medical Research Council of Canada 
Merck & Co., Inc. 
Merck, Sharpe & Dohme Research 
Laboratories 
Merrell-National Laboratories 
Milbank Memorial Fund 
Miles Laboratories 
Mrs. Alfred E. Mirsky 
Mr. Arthur Montgomery 
Mrs. Maurice Moore 
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Multiple Sclerosis Society of Ganada 
Muscular Dystrophy Association 
The National Association for Mental Health, Inc. 
National Council on Alcoholism 
National Dairy Council 
National Endowment for the Humanities 
The National Foundation 
National Institute of Education 
National Kidney Foundation 
National Leukemia Association 
National Live Stock and Meat Board 
National Multiple Sclerosis Society 
National Planning Association 
National Science Foundation 
National Society for the Prevention of 
Blindness, Inc. 
Helen Newman Fund 
Philip F. Newman, Esq. 
New York Arthritis Foundation 
New York City Health Services Administration 
New York Heart Association 
New York State Division of Substance Abuse 
Services 
New York State Health Research Council 
North Atlantic Treaty Organization 
Nu Dimensions 
The Nutrition Foundation, Inc. 
Mr. Howard M. Pack 
Mr. Milton J. Petrie 
Pfizer, Inc. 
The Carl and Lily Pforzheimer Foundation, Inc. 
Pharmaceutical Manufacturers Association 
Foundation 
Philip Morris U.S.A. 
Mr. Seymour J. Phillips 
Mr. Martin Polinger 
The Population Council 
Stanley E. Read, M. D. 
Research Corporation 
Alfred A. Richman, M. D. 
The Rockefeller Foundation 
Felix G. Rohatyn Foundation, Inc. 
Damon Runyon-Walter Winchell Cancer Fund 
Mr. Charles Schnurmacher 
Scottish Rite Schizophrenic Research Program 
G.D. Searle & Company Laboratories
Sheriff Fund 
Robert and Gail Siegal Foundation 
Mr. Charles H. Silver 
Mr. Herbert M. Singer 
S. L. E. Foundation of America
Alfred P. Sloan Foundation
SmithKline Corporation
Social Science Research Council
Spafas, Inc.
Mr. Maury L. Spanier
Swiss National Foundation
Mr. Herbert Tenzer
UNICO National: Cooley's Anemia
Committee 
United States Brewers Association, Inc. 
Upjohn Company 
U.S. Air Force Office 
of Scientific Research 
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U.S. Army Medical Research and 
Development Command 
USDA Science and Education Administration 
U.S. Department of Energy 
U.S. National Aeronautics & Space 
Administration 
U.S. Navy 
U.S. Public Health Service: National 
Institutes of Health 
The Vanneck-Bailey Foundation 
Velutini Fund 
Weight Watchers International, Inc. 
The Whitehall Foundation, Inc. 
The Helen Hay Whitney Foundation 
The Wistar Institute 
Lester and Kathryn Wolfe Foundation, Inc. 
World Health Organization 
The Rockefeller University Annual Giving Program 1978-1979 
FOUNDER AS SOCIA TES 
(Donors of $5,000 or more per year) 
Mr. Ralph E. Ablon 
Mr. Herbert A. Allen 
Anonymous 
Mrs. Vincent Astor 
Mr. T. Roland Berner 
Mr. Nicholas F. Brady 
Eli Whitney Debevoise, Esq. 
Mr. and Mrs. J. Richardson Dilworth 
Mr. and Mrs. Charles H. Dyson 
Mr. Richard M. Furlaud 
Mrs. Andrew Heiskell 
Mr. Harold F. Linder 
Mr. and Mrs. James A. Linen III 
Mr. and Mrs. John L. Loeb 
Mr. and Mrs. George D. O'Neill 
Peat, Marwick, Mitchell & Co. 
Mr. David Rockefeller 
Mr. Walter N. Rothschild, Jr. 
Mr. Fayez Sarofim 
Mr. and Mrs. Herbert M. Singer 
Mr. Robert G. Stone, Jr. 
Mr. Edwin C. Whitehead 
PRESIDENTIAL AS SOCIA TES 
(Donors of $1,000 to $4,999 per year) 
Mr. and Mrs. Frederick L. Adler 
Anonymous 
Mr. and Mrs. Robert Bach 
Mr. George F. Bennett 
Mr. and Mrs. Edward T. Chase 
Coopers and Lybrand 
Mrs. Susan L. Cullman 
Dresser Foundation 
Mr. and Mrs. Frederick Eberstadt 
The Equitable Life Assurance Society 
of the United States 
Mr. and Mrs. Alexander D. Forger 
Mr. Carl B. Hess 
Dr. and Mrs. Joshua Lederberg 
Samuel & Ethel LeFrak Foundation 
Mr. Henry Luce III 
Dr. and Mrs. Maclyn McCarty 
Mr. and Mrs. Brooks McCormick 
Mitsui & Co. (U.S.A.), Inc. 
Edward S. Moore Foundation 
Mrs. Jeffrey A. Moore 
Anne S. Richardson Fund 
Mr. Morris M. Schrier 
Seiden & deCuevas, Inc. 
Servomation Corporation 
William A. Shea, Esq. 
John R. Stevenson, Esq. 
Dr. W. Gordon Whaley 
James R. Withrow, Jr., Esq. 
MEMBERS 
(Donors of up to $1,000 per year) 
Alexander G. Beam, M.D. 
Charitable Foundation of the Bums Family 
Mr. and Mrs. Farnham Collins 
Mr. and Mrs. McCauley Conner 
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Mr. and Mrs. Peter Elder 
Mr. and Mrs. William Greenough 
Mr. and Mrs. Clifton H. Hipkins 
Mr. and Mrs. Frank L. Mansell 
Mr. and Mrs. Thomas Parsons III 
Mr. and Mrs. Harvey Picker 
Mr. Edwaro Robinson 
Mr. and Mrs. Martin E. Segal 
Mr. and Mrs. Masood R. Siddiqi 
Mr. and Mrs. Edmund A. Stanley 
Mr. and Mrs. J. Paul Sticht 
Mr. and Mrs. Frank Stubbs 
Mr. and Mrs. Don Summa 
Mrs. Margaret C. Weaver 
Dr. Chen Ning Yang 
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Washington, D.C. 
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Edward W. Carter, Chairman 
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Los Angeles, Cal. 
Guy Charlap, President 
Technicon Corporation, Tarrytown, N.Y.
Morris D. Crawford, Jr., Chairman 
The Bowery Savings Bank 
New York, N.Y. 
Susan L. Cullman, New York, N.Y. 
Joseph H. Davenport, Jr., Chairman 
Volunteer State Life Insurance Company 
Chattanooga, Tenn. 
Dr. Edward E. David, Jr., President 
Exxon Research & Engineering Company 
Florham Park, N .J. 
Michel David-Weill, Senior Partner 
Lazard-F!eres, New York, N.Y. 
John Diebold, Chairman 
The Diebold Group, Inc., New York, N.Y. 
John T. Dorrance, Chairman & Director 
Campbell Soup Company, Camden, N.J. 
Thomas E. Drohan 
President and Chief Executive Officer 
Foremost-McKesson, Inc. 
San francisco, Cal. 
Charles H. Dyson, Chairman 
Dyson-Kissner Corporation 
New York, N.Y. 
Oscar Dystel, President 
Bantam Books, Inc., New York, N.Y. 
Dr. Stanley D. Frank 
Executive Vice President 
CBS Publishing Group, New York, N.Y. 
H. Clay Frick II, M.D.
Columbia Presbyterian Hospital
New York, N.Y.
Robert W. Galvin, Chairman 
Motorola, Inc., Schaumburg, Ill. 
Dr. Eugene Garfield, President 
Institute for Scientific Information 
Philadelphia, Pa. 
Carl A. Gerstacker, Director 
The Dow Chemical Company, Midland, Mic: 
William T. Golden, Director 
General American Investors Corporation 
New York, N.Y. 
Dr. William C. Greenough, Chairman 
Teachers Insurance and Annuity Association 
New York, N.Y. 
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Bank of Tokyo, Ltd., Tokyo, Japan 
John D. Harper, Chairman 
Executive Committee 
Aluminum Company of America 
Pittsburgh, Pa. 
S. T. Harris, Director 
Texas Instruments Inc., Dallas, Texas 
Dr. Alexander Heard, Chancellor 
Vanderbilt University, Nashville, Tenn. 
Louis J. Hector, Esq., Partner 
Steel, Hector & Davis, Miami, Fla. 
The Honorable A. Leon Higginbotham, Jr. 
United States District Court Judge 
Philadelphia, Pa. 
Ada Louise Huxtable 
Member, Editorial Board 
The New·York Times, New York, N.Y. 
Vernon E. Jordan, Jr., Executive Director 
National Urban League, Inc. 
New York, N.Y. 
Antonie T. Knoppers, M.D., Summit, N.J. 
Baron Leon Lambert 
Banque Lambert, Brussels, Belgium 
Dr. Gerald D. Laubach, President 
Pfizer, Inc., New York, N.Y. 
Mary Wells Lawrence, President 
Wells, Rich, Greene, Inc., New York, N.Y. 
Ralph Lazarus, Chairman 
Federated Department Stores, Inc. 
Cincinnati, Ohio 
H. W. Lee, Director 
Lee Hysan Estate Co., Ltd., Hong Kong 
John H. Loudon 
The Hague, Netherlands 
Henry Luce III, Vice President 
Time, Inc., New York, N.Y. 
Bayless Manning, Esq., Partner 
Paul, Weiss, Rifkind, Wharton & Garrison 
New York, N.Y. 
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Dean A. McGee, Chairman 
Kerr-McGee Corporation 
Oklahoma City, Okla. 
Dr. Ruben F. Mettler, Chairman 
TRW Inc., Cleveland, Ohio 
Elisabeth L. Moore, New York, N.Y. 
Phil R. North, Chairman of the Board 
Tandy Corporation, Fort Worth, Texas 
Suliman S. Olayan, Chairman 
The Olayan Group, Jeddah, Saudi Arabia 
Anthony J. F. O'Reilly 
Chief Executive Officer 
H.J. Heinz Company, Pittsburgh, Pa. 
Sir Yue-Kong Pao, Chairman 
World-Wide (Shipping) Ltd., Hong Kong 
Gladys T. Perkin, New Canaan, Conn. 
Carl H. Pforzheimer, Jr., Senior Partner 
Carl H. Pforzheimer & Company 
New York, N.Y. 
Gerard Piel, President 
Scientific American, Inc., New York, N.Y. 
Claude Ramsey, Chairman and President 
Akzona Inc., Asheville, N.C. 
Dr. Gordon N. Ray, President 
John Simon Guggenheim Memorial 
Foundation 
New York, N.Y. 
Dina Merrill Robertson, New York, N. Y. 
James D. Robinson III, Chairman 
American Express Company, New York, N.Y. 
Louis H. Roddis, Jr., P.E. 
Consulting Engineer, Charleston, S.C. 
Lord Roll of lpsden, Chairman 
S.G. Warburg & Company, Ltd. 
London, England 
Dr. George Rosenkranz 
Chairman and Chief Executive Officer 
Syntex Corporation, Mexico, D.F. 
Anton E. Rupert, Chairman 
Rembrandt Group of Companies 
Stellenbosch, South Africa 
Arthur M. Sackler, M.D., New York, N.Y. 
Richard B. Salomon 
Riverbank Associates, New York, N.Y. 
Fayez Sarofim, President 
Fayez Sarofim & Company, Houston, Texas 
Morris M. Schrier, Vice �resident, Secretary 
MCA, Inc., New York, N.Y. 
Natalie Schwartz, Rancho Mirage, Cal. 
Richard J. Schwartz, Chairman and Pr�sident 
Jonathan Logan, Inc., New York, N.Y. 
· David C. Scott, Chairman and President
Allis-Chalmers Corporation
Milwaukee, Wis. 
Dr. Frederick Seitz, President Emeritus 
The Rockefeller University, New York, N.Y. 
Richard R. Shinn, President 
Metropolitan Life Insurance Company 
New York, N.Y. 
Herbert M. Singer, Esq., Partner 
Singer & Corwin, New York, N .Y. 
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August Thyssen-Hiitte 
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Colin Stokes 
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Jackson W. Tarver, President 
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